Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2443-2446

  Venkateswarlu, K ^a   Denning, David W ^b   Manning, Nigel J ^c   Kelly, Steven L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ARTICLE; CANDIDA KRUSEI; CANDIDIASIS; CELL LEVEL; DRUG ACCUMULATION; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; STEROL ANALYSIS;

EID: 0029998562     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2443     Document Type: Article

References (43)

1. Baily, G. G., F. M. Perry, D. W. Denning, and B. K. Mandal. 1994. Fluconazole-resistant candidosis in an HIV cohort. AIDS 8:787-792.
2. Ballard, S. A., S. W. Ellis, S. L. Kelly, and P. F. Troke. 1990. A novel method for studying ergosterol biosynthesis by cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents. J. Med. Vet. Mycol. 28:335-344.
3. Ballard, S. A., S. L. Kelly, S. W. Ellis, and P. F. Troke. 1990. Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole. J. Med. Vet. Mycol. 28:327-334.
4. de Waard, M. A., and J. G. M. Van Nisterlrooy. 1988. Accumulation of SBI fungicide in wild-type and fenarimol-resistant isolates of Penicillium italicum. Pestic. Biochem. Physiol. 22:371-382.
5. Dupont, B. 1994. Invasive fungal infections caused by yeasts as emerging pathogens. Infect. Dis. Clin. Pract. 3(Suppl. 2):S78-S82.
6. Ebert, E., W. Gaudin, W. Muecke, K. Ramssteiner, and C. Vogel. 1982. Inhibition of ergosterol biosynthesis by etaconazole in Ustilago maydis. Z. Naturforsch. 38:28-34.
7. Fling, M. E., J. Kopf, A. Tamarkin, J. A. Gorman, H. A. Smith, and Y. Koltin. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:318-329.
8. Higgins, C. F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:67-113.
9. Hitchcock, C. A. 1993. Resistance of Candida albicans to antifungal agents. Biochem. Soc. Trans. 41:1039-1047.
10. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1986. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J. Gen. Microbiol. 132:2421-2431.
11. Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1987. Inhibition of 14α-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole. J. Med. Vet. Mycol. 25:329-333.
12. Joseph-Horne, T., D. Hollomon, R. S. T. Loeffler, and S. L. Kelly. 1995. Altered P450 activity associated with direct selection for fungal azoic resistance. FEBS Lett. 374:174-178.
13. Joseph-Horne, T., D. Hollomon, R. S. T. Loeffler, and S. L. Kelly. 1995. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans. Antimicrob. Agents Chemother. 39:1526-1529.
14. 5(6) desaturase as a cause of azole resistance in Ustilago maydis. FEMS Microbiol. Lett. 127:29-34.
15. Kalamarakis, A. E., M. A. De Waard, B. N. Ziogas, and S. G. Georgopoulos. 1991. Resistance to fenarimol in Nectria haematococc var. cucurbitae. Pestic. Biochem. Physiol. 40:212-220.
16. Kelly, S. L., and D. E. Kelly. 1993. Molecular studies on azole sensitivity in fungi, p. 199-213. In B. Maresca, G. S. Kobayashi, and H. Yamaguchi (ed.), Molecular biology and applications of medical mycology. Springer-Verlag, Berlin.
17. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance of azole antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol. Biochem. Biophys. Res. Commun. 207:910-915.
18. Lamb, D. C., A. Corran, B. C. Baldwin, J. Kwonchung, and S. L. Kelly. 1995. Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients. FEBS Lett. 368:326-330.
19. Lees, W. D., M. C. Broughton, D. Sanglard, and M. Bard. 1990. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans. Antimicrob. Agents Chemother. 34:831-836.
20. Loeffler, R. S. T., and A. L. Hayes. 1990. Sterols of the plant pathogenic fungi Botrytis cinera and Pyrenophora teres. Phytochemistry 29:3423-3425.
21. Loeffler, R. S. T., and A. L. Hayes. 1992. Effects of sterol biosynthesis inhibitor fungicides on growth and sterol composition of Ustilago maydis, Botrytis cinera and Pyrenophora teres. Pestic. Sci. 35:7-17.
22. Marichal, P., J. Gorrens, M.-C. Coene, L. Le Jeune, and H. Vanden Bossche. 1995. Origin of differences in susceptibility of Candida krusei to azole antifungal agents. Mycoses 38:111-117.
23. Marichal, P., and H. Vanden Bossche. 1995. Mechanisms of resistance to azole antifungals. Acta Biochim. Polon. 42:509-515.
24. Neyfakh, A. A., V. E. Bidnenko, and L. B. Chen. 1991. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc. Natl. Acad. Sci. USA 88:4781-4785.
25. Norman, A. W., A. M. Spielvogel, and R. G. Wong. 1976. Polyene antibiotic sterol interaction. Adv. Lipid Res. 14:127-170.
26. Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. J. Biol. Chem. 239:2370-2378.
27. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1691.
28. Pfaller, M. A., and A. L. Barry. 1994. Evaluation of a novel colorimetric broth in microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
29. Prasad, R., P. Dewergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
30. Quail, M. A., A. Arnoldi, D. J. Moore, M. W. Goosey, and S. L. Kelly. 1993. Ketoconazole mediated growth inhibition in Botrytis cinera and Saccharomyces cerevisiae. Phytochemistry 32:273-280.
31. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
32. Scholer, H. J., and A. Polak. 1984. Resistance to systemic antifungal agents, p. 393-483. In L. E. Bryan (ed.), Antimicrobial drug resistance. Academic Press, Inc., New York.
33. Shimokawa, O., and H. Nakayama. 1991. Phenotypes of Candida albicans mutants deficient in Δ8,7-isomerisation or 5 desaturation. J. Med. Vet. Mycol. 29:53-56.
34. Vanden-Bossche, H. 1985. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action, p. 313-351. In M. R. McGinnis (ed.), Current topics in medical mycology, vol. 1. Springer-Verlag, New York.
35. Vanden Bossche, H. P., Marichal, J. Gorrens, H. Geerts, and P. A. J. Janssen. 1988. Mode of action studies, basis for the search for new antifungal drugs. Ann. N. Y. Acad. Sci. 544:191-207.
36. Vanden Bossche, H., P. Marichal, and H. Moereels. 1993. Molecular mechanisms of antifungal activity and fungal resistance: focus on inhibitors of ergosterol biosynthesis, p. 179-197. In B. Maresca, G. S. Kobayashi, and H. Yamaguchi (ed.), Molecular biology and applications to medical mycology. Springer-Verlag, Berlin.
37. Vanden Bossche, H., P. Marichal, F. C. Odds, L. Le Jeune, and M.-C. Coene. 1992. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36:2602-2610.
38. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1995. Resistance Io ftuconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microhiol. Lett. 131: 337-341.
39. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1996. Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P450 by using in vitro assays. Antimicrob. Agents Chemother. 40:1382-1386.
40. Wardle, H. M., D. Law, C. B. Moore, C. Mason, and D. W. Denning. 1995. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrob. Agents Chemother. 39:868-871.
41. Watson, P. F., M. E. Rose, S. W. Ellis, H. England, and S. L. Kelly. 1989. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals. Biochem. Biophys. Res. Commun. 164:1170-1175.
42. Wingard, J. R. 1994. Changes in the spectrum of fungal infections in bone marrow transplant patients. Infect. Dis. Clin. Pract. 3(Suppl. 2):S83-S89.
43. Woods, R. A. 1971. Nystatin-resistant mutants of yeast: alteration in sterol content. J. Bacteriol. 108:68-73.